NFE2L2 and cystic fibrosis: Similarly to curcumin, resveratrol, a polyphenolic compound containing α,β-unsaturated carbonyl groups and possessing Nrf2-activating properties [103], manifested initial promise as a potential therapeutic agent for CF.